Chr. Hansen sees ‘solid’ growth

Chr. Hansen saw solid organic revenue growth of 9% in the first nine months of 2014/15 to €228.1 million: Cultures & Enzymes Division grew by 8%, Health & Nutrition Division 17% and Natural Colors Division 7%. EBIT before special items increased by 12% to €160 million. Revenue measured in € increased by 13%, as Chr. […]

Chr. Hansen saw solid organic revenue growth of 9% in the first nine months of 2014/15 to €228.1 million: Cultures & Enzymes Division grew by 8%, Health & Nutrition Division 17% and Natural Colors Division 7%. EBIT before special items increased by 12% to €160 million. Revenue measured in € increased by 13%, as Chr. Hansen was positively impacted by the appreciation of the US$

“The performance in the first nine months of 2014/15 was encouraging with good progress across our divisions and strategic initiatives,” said CEO Cees de Jong. “Based on this we have narrowed our organic revenue expectations for 2014/15 to 8-9% (previously 7-9%). The EBIT margin is still expected to be above 26.5%, while free cash flow is now expected to be around EUR 150 million (previously above EUR 130 million).”